(Q28371036)

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Classification and nomenclature of 5-HT receptors: a comment on current issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Functional characteristics of heterologously expressed 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

A subfamily of 5-HT1D receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

5-HT 1B/D receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Human serotonin1B receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Dopamine D2 receptor dimers in human and rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Dimerization of the delta opioid receptor: implication for a role in receptor internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Dopamine D2 receptor dimers and receptor-blocking peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Operational studies of synergistic interactions with 5-HT1B/1D receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

GABA(B)-receptor subtypes assemble into functional heteromeric complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Heterodimerization is required for the formation of a functional GABA(B) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Role of heteromer formation in GABAB receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Serotonin Dimers: Application of the Bivalent Ligand Approach to the Design of New Potent and Selective 5-HT1B/1DAgonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Metabotropic glutamate receptor 5 is a disulfide-linked dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

The structure and signalling properties of 5-HT receptors: an endless diversity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

Interactions between effectors linked to serotonin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900918-7

10.1016/S0014-5793(99)00918-7

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ow2evio5trgtrbw5flpesbc6ve

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_ow2evio5trgtrbw5flpesbc6ve

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ow2evio5trgtrbw5flpesbc6ve

mapped directly with Wikidata item

30 July 2022

based on heuristic

OpenCitations bibliographic resource ID

3057235

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3057235

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/ow2evio5trgtrbw5flpesbc6ve